Comparative Long-Term Preclinical Safety Evaluation of Two Glatiramoid Compounds (Glatiramer Acetate, Copaxone®, and TV-5010, Protiramer) in Rats and Monkeys

Glatiramer acetate for treatment of MS: Regulatory B cells join the cast of players

(2010) Luc Van Kaer   EXPERIMENTAL NEUROLOGY

Glatiramer acetate and the glatiramoid class of immunomodulator drugs in multiple sclerosis: an update

(2010) Kenneth P Johnson   Expert Opinion on Drug Metabolism & Toxicology

Safety, Pharmacokinetic, and Pharmacodynamic Evaluations of PI-2301, a Potent Immunomodulator, in a First-in-Human, Single-Ascending-Dose Study in Healthy Volunteers

(2010) Joseph Kovalchin et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Results of a phase I study in patients suffering from secondary-progressive multiple sclerosis demonstrating the safety of the amino acid copolymer PI-2301 and a possible induction of an anti-inflammatory cytokine response☆

(2010) J. Kovalchin et al.   JOURNAL OF NEUROIMMUNOLOGY

A comparison of rat chronic progressive nephropathy with human renal disease—implications for human risk assessment

(2009) Gordon C. Hard et al.   CRITICAL REVIEWS IN TOXICOLOGY

The glatiramoid class of immunomodulator drugs

(2009) Haim Varkony et al.   EXPERT OPINION ON PHARMACOTHERAPY

Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate

(2009) Ruth Arnon et al.   JOURNAL OF NEURAL TRANSMISSION

Impact of Warm Compresses on Local Injection-Site Reactions with Self-Administered Glatiramer Acetate

(2009) Helen Jolly et al.   JOURNAL OF NEUROSCIENCE NURSING

Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role

(2009) Roland Liblau   JOURNAL OF THE NEUROLOGICAL SCIENCES

Factitial Panniculitis

(2008) Onofre Sanmartín et al.   DERMATOLOGIC CLINICS

Predictivity of animal studies for human injection site reactions with parenteral drug products

(2008) Jeffery A. Engelhardt   EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY

Glatiramer Acetate

(2008) François Blanchette et al.   JOURNAL OF NEUROLOGY

The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing–remitting multiple sclerosis

(2008) N De Stefano et al.   Multiple Sclerosis Journal

Microbiology and management of soft tissue and muscle infections

(2007) Itzhak Brook   International Journal of Surgery